Phoenix Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 10 Year, 10 Days
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 57.29%
- Profit Growth 59.62%
- Ebitda 47.84%
- Net Worth 31.58%
- Total Assets -22.10%
About Phoenix Pharma
Phoenix Pharma Private Limited (PPPL) is a Private Limited Indian Non-Government Company incorporated in India on 19 January 2015 and has a history of Ten years. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Saurabh Sangore and Shilpa Sangore serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U74990MH2015PTC261092
- Company No.
261092
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Jan 2015
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Phoenix Pharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Saurabh Sangore  | Director | 19-Jan-2015 | Current |
| Shilpa Sangore | Additional Director | 01-Dec-2015 | Current |
Financial Performance of Phoenix Pharma.
Phoenix Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 57.29% increase. The company also saw a substantial improvement in profitability, with a 59.62% increase in profit. The company's net worth Soared by an impressive increase of 31.58%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Phoenix Pharma?
In 2022, Phoenix Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Phoenix Hospitals Private LimitedSaurabh Sangore is a mutual person
Phoenix Medisurg LlpSaurabh Sangore is a mutual person
- Facematic Aesthetics Llp
Saurabh Sangore is a mutual person
- Phoenix Infra Residency Private Limited
Saurabh Sangore and Shilpa Sangore are mutual person
- Motherland Hospitals Private Limited
Saurabh Sangore and Shilpa Sangore are mutual person
- Speed Diagnostics Private Limited
Shilpa Sangore is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Phoenix Pharma?
Unlock and access historical data on people associated with Phoenix Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Phoenix Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Phoenix Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
